nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair—Proficient Colorectal or Pancreatic Cancer
|
Hernando-Calvo, Alberto |
|
|
23 |
3 |
p. 272-284.e9 |
artikel |
2 |
BRAFV600E -Mutant Metastatic Colorectal Cancer: Current Evidence, Future Directions, and Research Priorities
|
Piercey, Oliver |
|
|
23 |
3 |
p. 215-229 |
artikel |
3 |
Brazil-TNT: A Randomized Phase 2 Trial of Neoadjuvant Chemoradiation Followed by FOLFIRINOX Versus Chemoradiation for Stage II/III Rectal Cancer
|
Bugano, Diogo Diniz Gomes |
|
|
23 |
3 |
p. 238-244 |
artikel |
4 |
Clinical and Molecular Variables Associated With Early Progression to Checkpoint Inhibitors in MSI-High Metastatic Colorectal Cancer: A Retrospective Cohort Study
|
Hulst, L. |
|
|
23 |
3 |
p. 230-237.e1 |
artikel |
5 |
Clinical Outcomes in T4 and/or N2 Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy: A Retrospective Study
|
Unrau, Sarah |
|
|
23 |
3 |
p. 251-257 |
artikel |
6 |
Determinants of Metastatic Colorectal Cancer With Permanent Liver- Limited Disease
|
SalvĂ , Francesc |
|
|
23 |
3 |
p. 207-214 |
artikel |
7 |
Editorial Board
|
|
|
|
23 |
3 |
p. A1 |
artikel |
8 |
KRAS G12C Inhibitors in the Treatment of Metastatic Colorectal Cancer
|
Xiao, Annie |
|
|
23 |
3 |
p. 199-206 |
artikel |
9 |
Potential for Metastasis and Recurrence in Colorectal Carcinoma In Situ: A Retrospective Analysis of 1069 Patients
|
Kim, Seijong |
|
|
23 |
3 |
p. 245-250 |
artikel |
10 |
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab in Patients With Advanced or Metastatic Microsatellite Stable Colorectal Cancer
|
Bessudo, Alberto |
|
|
23 |
3 |
p. 285-294 |
artikel |
11 |
Table of contents
|
|
|
|
23 |
3 |
p. A3-A4 |
artikel |
12 |
Use of FOLFOXIRI Plus Bevacizumab and Subsequent Therapies in Metastatic Colorectal Cancer: An Age-Stratified Analysis
|
Vassilev, Zdravko P. |
|
|
23 |
3 |
p. 258-271.e1 |
artikel |